13F

PCRX PACIRA BIOSCIENCES INC

2026Q1 · CUSIP 695127100 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
237
Δ holders QoQ
-25
Breadth percentile
Top 94%
Whale holders
126
Δ whales
-10
Inst. holding value
$974M
New positions
28
Closed positions
53
Price momentum (1Q)
-1.3%
Put / Call
1/1

Breadth history (34 quarters)

2018Q1: Δ-17 · h=169 2018Q2: Δ-13 · h=156 2018Q3: Δ+30 · h=186 2018Q4: Δ+21 · h=207 2019Q1: Δ+2 · h=209 2019Q2: Δ+10 · h=219 2019Q3: Δ-7 · h=212 2019Q4: Δ+20 · h=232 2020Q1: Δ-7 · h=225 2020Q2: Δ+23 · h=248 2020Q3: Δ+11 · h=259 2020Q4: Δ+1 · h=260 2021Q1: Δ+8 · h=268 2021Q2: Δ-6 · h=262 2021Q3: Δ-2 · h=260 2021Q4: Δ+15 · h=275 2022Q1: Δ+27 · h=302 2022Q2: Δ-19 · h=283 2022Q3: Δ-11 · h=272 2022Q4: Δ+3 · h=275 2023Q1: Δ-7 · h=268 2023Q2: Δ-12 · h=256 2023Q3: Δ+6 · h=262 2023Q4: Δ-1 · h=261 2024Q1: Δ+10 · h=271 2024Q2: Δ+10 · h=281 2024Q3: Δ-42 · h=239 2024Q4: Δ-3 · h=236 2025Q1: Δ+1 · h=237 2025Q2: Δ-4 · h=233 2025Q3: Δ+6 · h=239 2025Q4: Δ+23 · h=262 2026Q1: Δ-25 · h=237 2018Q1: holders=169 2018Q2: holders=156 2018Q3: holders=186 2018Q4: holders=207 2019Q1: holders=209 2019Q2: holders=219 2019Q3: holders=212 2019Q4: holders=232 2020Q1: holders=225 2020Q2: holders=248 2020Q3: holders=259 2020Q4: holders=260 2021Q1: holders=268 2021Q2: holders=262 2021Q3: holders=260 2021Q4: holders=275 2022Q1: holders=302 2022Q2: holders=283 2022Q3: holders=272 2022Q4: holders=275 2023Q1: holders=268 2023Q2: holders=256 2023Q3: holders=262 2023Q4: holders=261 2024Q1: holders=271 2024Q2: holders=281 2024Q3: holders=239 2024Q4: holders=236 2025Q1: holders=237 2025Q2: holders=233 2025Q3: holders=239 2025Q4: holders=262 2026Q1: holders=237 -42 -21 +0 +21 +42 140229318 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 5 lit events

Period Percentile Next-1Q return Next-2Q return
2022Q1 Top 6% -8.6% -21.4%
2020Q2 Top 15% +2.2% +19.3%
2019Q2 Top 14% +11.4% +31.0%
2018Q4 Top 11% +8.5% -5.1%
2018Q3 Top 5% -15.4% -7.1%

Options Sentiment

Put holders
1
QoQ: 0
Call holders
1
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
193.5
EPS (TTM)
$0.13
EPS YoY
Revenue (TTM)
$0.7B
Revenue YoY
+4.6%
Quarterly Revenue & EPS (4Y)
2022-06-30: $169M 2022-09-30: $167M 2022-12-31: $172M 2023-03-31: $160M 2023-06-30: $169M 2023-09-30: $164M 2023-12-31: $181M 2024-03-31: $167M 2024-06-30: $178M 2024-09-30: $169M 2024-12-31: $187M 2025-03-31: $169M 2025-06-30: $181M 2025-09-30: $180M 2025-12-31: $197M 2026-03-31: $177M 2022-06-30: EPS 0.40 2022-09-30: EPS -0.02 2022-12-31: EPS -0.19 2023-03-31: EPS -0.43 2023-06-30: EPS 0.51 2023-09-30: EPS 0.23 2023-12-31: EPS 0.58 2024-03-31: EPS 0.19 2024-06-30: EPS 0.39 2024-09-30: EPS -3.11 2024-12-31: EPS 0.38 2025-03-31: EPS 0.10 2025-06-30: EPS -0.11 2025-09-30: EPS 0.12 2025-12-31: EPS 0.05 2026-03-31: EPS 0.07 0M 98M 197M $M -3.42 -1.39 0.64 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 49 2023-09-30: PE 232.92023-12-31: PE 32.72024-03-31: PE 20.42024-06-30: PE 9.32025-09-30: PE 48.52025-12-31: PE 136.12026-03-31: PE 174.2 8 126 245 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)